Friedenthal Financial Has $808,000 Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Friedenthal Financial raised its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 961.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,359 shares of the biotechnology company's stock after purchasing an additional 1,231 shares during the quarter. Friedenthal Financial's holdings in Axon Enterprise were worth $808,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Brookstone Capital Management lifted its holdings in Axon Enterprise by 27.0% during the 4th quarter. Brookstone Capital Management now owns 974 shares of the biotechnology company's stock valued at $579,000 after purchasing an additional 207 shares during the last quarter. Winthrop Advisory Group LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $236,000. Czech National Bank raised its stake in shares of Axon Enterprise by 7.4% in the fourth quarter. Czech National Bank now owns 15,707 shares of the biotechnology company's stock valued at $9,335,000 after acquiring an additional 1,082 shares during the last quarter. Graypoint LLC acquired a new position in shares of Axon Enterprise in the 4th quarter worth approximately $258,000. Finally, HBW Advisory Services LLC acquired a new stake in Axon Enterprise during the 4th quarter valued at $295,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Trading Down 0.2 %

Shares of Axon Enterprise stock traded down $1.32 during trading on Monday, hitting $568.68. 422,401 shares of the company were exchanged, compared to its average volume of 713,926. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a market capitalization of $43.36 billion, a P/E ratio of 146.95, a price-to-earnings-growth ratio of 14.19 and a beta of 1.04. The firm's fifty day moving average price is $610.03 and its 200 day moving average price is $452.93. Axon Enterprise, Inc. has a 1-year low of $246.99 and a 1-year high of $698.67.

Insider Buying and Selling

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the sale, the director now owns 26,259 shares of the company's stock, valued at $11,500,916.82. This trade represents a 3.67 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 51,545 shares of company stock valued at $31,159,317 in the last 90 days. 6.10% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research firms have commented on AXON. TD Cowen assumed coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective on the stock. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a report on Monday, November 11th. Morgan Stanley upgraded shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and raised their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Needham & Company LLC upped their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a research report on Friday, November 8th. Finally, JMP Securities raised their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a report on Thursday, October 31st. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. According to MarketBeat, Axon Enterprise currently has a consensus rating of "Moderate Buy" and a consensus target price of $504.92.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.